Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.48 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.78.
Market Cap
8.48T
Revenue
4.52T
Profits
203.04B
PE Ratio
41.78
Profit Margin
4.49%
Dividend Yield
0.44%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 818.46B | 1.46% | 635,653 | 65.18B |
| 2 | AZN | AstraZeneca PLC | 583.43B | 1.24% | 476,901 | 58.74B |
| 3 | JNJ | Johnson & Johnson | 580.51B | 2.39% | 2,044,437 | 94.19B |
| 4 | ABBV | AbbVie Inc. | 368.59B | 1.59% | 1,747,944 | 61.16B |
| 5 | MRK | Merck & Co., Inc. | 295.57B | 2.73% | 3,206,113 | 65.01B |
| 6 | NVS | Novartis AG | 289.39B | 2.05% | 354,215 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 244.43B | -1.10% | 2,988,100 | 447.57B |
| 8 | AMGN | Amgen Inc. | 191.93B | 2.18% | 456,551 | 36.75B |
| 9 | ABT | Abbott Laboratories | 181.74B | 0.50% | 1,434,362 | 44.33B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 181.23B | -0.50% | 512,845 | 44.56B |
| 11 | GILD | Gilead Sciences, Inc. | 173.67B | 1.30% | 1,243,335 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 167.39B | -0.12% | 390,909 | 10.06B |
| 13 | NVO | Novo Nordisk A/S | 163.55B | -0.70% | 7,193,455 | 48.59B |
| 14 | PFE | Pfizer Inc. | 156.03B | 1.78% | 10,033,780 | 62.58B |
| 15 | DHR | Danaher Corporation | 131.47B | -2.20% | 1,461,352 | 24.57B |
| 16 | SYK | Stryker Corporation | 124.44B | -1.01% | 454,124 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.31B | 2.94% | 3,101,676 | 48.19B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 116.40B | 2.14% | 350,844 | 12.00B |
| 19 | SNY | Sanofi | 112.31B | 2.02% | 565,214 | 54.85B |
| 20 | MDT | Medtronic plc | 111.84B | 0.61% | 2,188,874 | 35.48B |
| 21 | GSK | GSK plc | 110.86B | 2.89% | 1,935,022 | 43.97B |
| 22 | MCK | McKesson Corporation | 109.16B | 1.05% | 121,639 | 397.96B |
| 23 | HCA | HCA Healthcare, Inc. | 107.67B | -0.88% | 221,430 | 75.60B |
| 24 | BSX | Boston Scientific Corporation | 102.74B | 1.60% | 2,472,290 | 20.07B |
| 25 | CVS | CVS Health Corporation | 91.50B | -1.21% | 1,313,625 | 399.83B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.56B | 1.46% | 135,114 | 14.34B |
| 27 | CI | The Cigna Group | 70.55B | 0.69% | 891,605 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 64.40B | 0.51% | 394,476 | 199.13B |
| 29 | COR | Cencora, Inc. | 63.52B | -0.23% | 244,838 | 325.78B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 57.78B | 1.39% | 937,840 | 28.48B |
| 31 | MDLN | Medline Inc. | 55.82B | 1.09% | 1,426,829 | 28.43B |
| 32 | CAH | Cardinal Health, Inc. | 49.45B | 1.40% | 313,614 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 48.91B | -0.05% | 1,056,534 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 47.81B | 0.76% | 746,170 | 6.07B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 45.38B | -0.05% | 102,513 | 4.30B |
| 36 | BDX | Becton, Dickinson and Company | 44.53B | 0.30% | 397,716 | 21.92B |
| 37 | HLN | Haleon plc | 43.41B | 0.46% | 2,484,725 | 14.85B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.04B | 5.35% | 319,089 | 3.71B |
| 39 | ARGX | argenx SE | 42.88B | 2.28% | 151,650 | 4.24B |
| 40 | ALC | Alcon Inc. | 36.38B | 0.53% | 385,452 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 34.24B | 2.20% | 4,143,060 | 17.26B |
| 42 | GEHC | GE HealthCare Technologies Inc. | 33.06B | 2.24% | 810,097 | 20.63B |
| 43 | RMD | ResMed Inc. | 32.92B | -0.96% | 1,018,036 | 5.40B |
| 44 | A | Agilent Technologies, Inc. | 31.96B | -0.98% | 362,836 | 7.07B |
| 45 | INSM | Insmed Incorporated | 31.81B | 6.06% | 656,013 | 606.42M |
| 46 | ONC | BeOne Medicines AG | 31.29B | 2.40% | 50,179 | 5.34B |
| 47 | WAT | Waters Corporation | 29.43B | -0.63% | 465,065 | 3.17B |
| 48 | VEEV | Veeva Systems Inc. | 29.00B | -0.87% | 411,219 | 3.20B |
| 49 | IQV | IQVIA Holdings Inc. | 27.97B | -0.77% | 285,461 | 16.31B |
| 50 | NTRA | Natera, Inc. | 27.62B | 1.65% | 300,445 | 2.31B |
| 51 | BIIB | Biogen Inc. | 27.58B | 2.18% | 328,596 | 9.89B |
| 52 | MTD | Mettler-Toledo International Inc. | 25.56B | -0.56% | 26,601 | 4.03B |
| 53 | PHG | Koninklijke Philips N.V. | 25.53B | 2.39% | 607,970 | 20.94B |
| 54 | DXCM | DexCom, Inc. | 25.52B | -0.42% | 868,988 | 4.66B |
| 55 | UTHR | United Therapeutics Corporation | 23.89B | 2.48% | 146,870 | 3.18B |
| 56 | BNTX | BioNTech SE | 22.37B | 2.51% | 193,841 | 3.37B |
| 57 | LH | Labcorp Holdings Inc. | 22.08B | 0.70% | 114,829 | 13.95B |
| 58 | STE | STERIS plc | 21.78B | 0.16% | 185,247 | 5.83B |
| 59 | DGX | Quest Diagnostics Incorporated | 21.61B | 0.21% | 119,222 | 11.04B |
| 60 | MRNA | Moderna, Inc. | 21.18B | 4.46% | 1,633,889 | 1.94B |
| 61 | HUM | Humana Inc. | 20.66B | -0.52% | 191,289 | 129.66B |
| 62 | EXAS | Exact Sciences Corporation | 20.03B | 0.95% | 21,548,536 | 3.25B |
| 63 | RPRX | Royalty Pharma plc | 19.87B | 1.76% | 608,657 | 2.38B |
| 64 | ROIV | Roivant Sciences Ltd. | 19.79B | 2.90% | 974,334 | 13.31M |
| 65 | RVMD | Revolution Medicines, Inc. | 19.09B | 0.84% | 1,071,162 | - |
| 66 | ILMN | Illumina, Inc. | 18.94B | -1.70% | 410,586 | 4.34B |
| 67 | INCY | Incyte Corporation | 18.34B | 1.67% | 400,657 | 5.14B |
| 68 | WST | West Pharmaceutical Services, Inc. | 17.71B | 0.24% | 166,724 | 3.07B |
| 69 | THC | Tenet Healthcare Corporation | 17.23B | -0.74% | 96,272 | 21.31B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 17.20B | 0.54% | 601,742 | 8.23B |
| 71 | HOLX | Hologic, Inc. | 16.87B | 0.08% | 877,024 | 4.13B |
| 72 | CNC | Centene Corporation | 15.74B | -2.97% | 1,624,888 | 176.15B |
| 73 | GMAB | Genmab A/S | 15.70B | 1.12% | 1,208,708 | 3.72B |
| 74 | VTRS | Viatris Inc. | 15.58B | 1.31% | 1,504,115 | 14.30B |
| 75 | PODD | Insulet Corporation | 15.55B | -2.02% | 149,328 | 2.71B |
| 76 | COO | The Cooper Companies, Inc. | 13.81B | 0.40% | 321,392 | 4.15B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.81B | 3.93% | 328,625 | 502.08M |
| 78 | SMMT | Summit Therapeutics Inc. | 13.78B | 14.38% | 2,410,201 | - |
| 79 | SNN | Smith & Nephew plc | 13.73B | 0.50% | 133,265 | 6.16B |
| 80 | ASND | Ascendis Pharma A/S | 13.65B | 3.16% | 103,572 | 845.52M |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.28B | 3.46% | 377,568 | 2.86B |
| 82 | MEDP | Medpace Holdings, Inc. | 13.23B | 1.18% | 204,516 | 2.53B |
| 83 | PEN | Penumbra, Inc. | 13.17B | 0.46% | 89,813 | 1.40B |
| 84 | ALGN | Align Technology, Inc. | 12.76B | -0.19% | 212,571 | 4.03B |
| 85 | ELAN | Elanco Animal Health Incorporated | 12.51B | 1.04% | 682,850 | 4.72B |
| 86 | FMS | Fresenius Medical Care AG | 12.35B | 0.36% | 115,864 | 23.05B |
| 87 | RGC | Regencell Bioscience Holdings Limited | 12.20B | 1.00% | 22,100 | - |
| 88 | IONS | Ionis Pharmaceuticals, Inc. | 12.11B | 5.17% | 1,056,965 | 943.71M |
| 89 | ENSG | The Ensign Group, Inc. | 11.83B | 0.29% | 177,449 | 5.06B |
| 90 | GMED | Globus Medical, Inc. | 11.67B | 0.19% | 161,864 | 2.94B |
| 91 | JAZZ | Jazz Pharmaceuticals plc | 11.63B | 2.16% | 326,945 | 4.27B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.54B | 3.01% | 658,921 | 3.85B |
| 93 | GH | Guardant Health, Inc. | 11.33B | 3.33% | 858,752 | 982.02M |
| 94 | UHS | Universal Health Services, Inc. | 11.28B | -0.72% | 202,450 | 17.36B |
| 95 | EXEL | Exelixis, Inc. | 11.15B | 3.25% | 627,115 | 2.32B |
| 96 | SOLV | Solventum Corporation | 11.10B | -0.11% | 285,309 | 8.33B |
| 97 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.70B | 4.77% | 87,148 | 958.40M |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.64B | 2.24% | 512,012 | 3.22B |
| 99 | DVA | DaVita Inc. | 10.25B | 0.09% | 100,764 | 13.64B |
| 100 | EHC | Encompass Health Corporation | 9.79B | 0.96% | 141,619 | 5.94B |
| 101 | RVTY | Revvity, Inc. | 9.77B | -0.08% | 488,163 | 2.86B |
| 102 | MASI | Masimo Corporation | 9.57B | -0.25% | 284,407 | 1.53B |
| 103 | PRAX | Praxis Precision Medicines, Inc. | 8.74B | 6.52% | 126,415 | 7.46M |
| 104 | QGEN | Qiagen N.V. | 8.72B | 1.08% | 485,990 | 2.09B |
| 105 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.69B | 10.27% | 1,063,055 | 1.09B |
| 106 | ABVX | ABIVAX Société Anonyme | 8.68B | 0.29% | 451,025 | 5.37M |
| 107 | BTSG | BrightSpring Health Services, Inc. | 8.66B | 3.35% | 1,051,317 | 12.91B |
| 108 | BAX | Baxter International Inc. | 8.62B | 0.18% | 1,625,020 | 11.24B |
| 109 | HSIC | Henry Schein, Inc. | 8.45B | -0.46% | 187,487 | 13.18B |
| 110 | TEM | Tempus AI, Inc. | 8.44B | -3.32% | 2,214,054 | 1.27B |
| 111 | IBRX | ImmunityBio, Inc. | 8.33B | 9.24% | 17,474,688 | 113.29M |
| 112 | AXSM | Axsome Therapeutics, Inc. | 8.26B | 1.72% | 125,332 | 638.50M |
| 113 | PCVX | Vaxcyte, Inc. | 8.23B | 4.58% | 619,234 | - |
| 114 | TECH | Bio-Techne Corporation | 8.19B | -0.16% | 533,625 | 1.22B |
| 115 | ATR | AptarGroup, Inc. | 8.09B | 1.17% | 77,591 | 3.78B |
| 116 | CRL | Charles River Laboratories International, Inc. | 7.94B | 1.32% | 218,418 | 4.02B |
| 117 | NUVL | Nuvalent, Inc. | 7.89B | 4.39% | 315,607 | - |
| 118 | CYTK | Cytokinetics, Incorporated | 7.58B | 2.52% | 738,263 | 88.04M |
| 119 | ICLR | ICON Public Limited Company | 7.56B | -2.29% | 158,278 | 8.10B |
| 120 | KRYS | Krystal Biotech, Inc. | 7.49B | 3.64% | 93,852 | 389.13M |
| 121 | HALO | Halozyme Therapeutics, Inc. | 7.46B | 1.87% | 233,827 | 1.40B |
| 122 | BIO | Bio-Rad Laboratories, Inc. | 7.31B | -0.50% | 61,462 | 2.58B |
| 123 | MOH | Molina Healthcare, Inc. | 7.09B | -2.86% | 211,403 | 43.56B |
| 124 | HQY | HealthEquity, Inc. | 6.86B | -1.16% | 157,864 | 1.31B |
| 125 | ACLX | Arcellx, Inc. | 6.70B | -0.15% | 395,525 | 22.29M |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 6.59B | 2.87% | 316,737 | 46.02M |
| 127 | KYMR | Kymera Therapeutics, Inc. | 6.59B | 8.45% | 235,128 | 39.21M |
| 128 | RGEN | Repligen Corporation | 6.43B | -1.88% | 299,767 | 738.26M |
| 129 | GKOS | Glaukos Corporation | 6.21B | 1.59% | 200,936 | 507.44M |
| 130 | BLTE | Belite Bio, Inc | 6.12B | 3.16% | 56,325 | - |
| 131 | AHG | Akso Health Group | 6.07B | 3.96% | 212,480 | 14.84M |
| 132 | COGT | Cogent Biosciences, Inc. | 6.00B | 5.66% | 696,833 | - |
| 133 | APGE | Apogee Therapeutics, Inc. | 5.77B | 13.77% | 1,781,857 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.70B | 1.04% | 463,628 | 189.76M |
| 135 | BLCO | Bausch + Lomb Corporation | 5.64B | 1.24% | 153,284 | 5.10B |
| 136 | CGON | CG Oncology, Inc. | 5.60B | 3.90% | 216,175 | 4.04M |
| 137 | PTCT | PTC Therapeutics, Inc. | 5.50B | 3.04% | 157,764 | 1.73B |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 5.46B | 2.99% | 137,935 | 521.31M |
| 139 | BRKR | Bruker Corporation | 5.36B | -1.65% | 900,654 | 3.44B |
| 140 | CAI | Caris Life Sciences, Inc. | 5.31B | -2.39% | 539,832 | 812.03M |
| 141 | XENE | Xenon Pharmaceuticals Inc. | 5.29B | 3.90% | 669,672 | 7.50M |
| 142 | PACS | PACS Group, Inc. | 5.20B | -1.93% | 185,883 | 5.29B |
| 143 | AVTR | Avantor, Inc. | 5.17B | -1.94% | 1,589,240 | 6.55B |
| 144 | TGTX | TG Therapeutics, Inc. | 5.13B | 6.25% | 767,860 | 616.29M |
| 145 | SRRK | Scholar Rock Holding Corporation | 5.10B | 4.85% | 571,043 | - |
| 146 | CHE | Chemed Corporation | 5.09B | -1.17% | 86,999 | 2.53B |
| 147 | IMVT | Immunovant, Inc. | 5.04B | 3.78% | 324,492 | - |
| 148 | CELC | Celcuity Inc. | 5.00B | 5.93% | 313,048 | - |
| 149 | ALKS | Alkermes plc | 4.89B | 3.42% | 329,292 | 1.48B |
| 150 | LNTH | Lantheus Holdings, Inc. | 4.84B | 0.82% | 133,846 | 1.54B |
| 151 | ERAS | Erasca, Inc. | 4.78B | 4.91% | 2,107,096 | - |
| 152 | TERN | Terns Pharmaceuticals, Inc. | 4.75B | 5.46% | 62,300,443 | - |
| 153 | TFX | Teleflex Incorporated | 4.74B | 0.58% | 172,551 | 1.99B |
| 154 | HIMS | Hims & Hers Health, Inc. | 4.74B | -2.62% | 8,786,463 | 2.35B |
| 155 | RDNT | RadNet, Inc. | 4.67B | 0.42% | 150,289 | 2.04B |
| 156 | CORT | Corcept Therapeutics Incorporated | 4.64B | 29.01% | 6,791,406 | 761.41M |
| 157 | MMED | Minimed Group, Inc. | 4.59B | 0.12% | 193,072 | 2.89B |
| 158 | CRSP | CRISPR Therapeutics AG | 4.58B | 2.71% | 365,172 | 3.51M |
| 159 | WAY | Waystar Holding Corp. | 4.53B | -1.66% | 299,402 | 1.10B |
| 160 | FOLD | Amicus Therapeutics, Inc. | 4.53B | 0.07% | 580,522 | 634.21M |
| 161 | OPCH | Option Care Health, Inc. | 4.47B | 0.49% | 297,826 | 5.65B |
| 162 | DOCS | Doximity, Inc. | 4.37B | -2.75% | 573,551 | 637.78M |
| 163 | NVST | Envista Holdings Corporation | 4.24B | -0.67% | 461,024 | 2.72B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 4.14B | 3.00% | 34,230 | 268.09M |
| 165 | MMSI | Merit Medical Systems, Inc. | 4.01B | -0.12% | 161,726 | 1.52B |
| 166 | STVN | Stevanato Group S.p.A. | 3.94B | 0.77% | 74,663 | 1.39B |
| 167 | IRTC | iRhythm Holdings, Inc. | 3.91B | 2.03% | 221,156 | 747.14M |
| 168 | SHC | Sotera Health Company | 3.90B | -0.98% | 432,415 | 1.16B |
| 169 | VKTX | Viking Therapeutics, Inc. | 3.86B | 3.95% | 762,917 | - |
| 170 | AMRX | Amneal Pharmaceuticals, Inc. | 3.84B | 1.24% | 165,348 | 3.02B |
| 171 | CNTA | Centessa Pharmaceuticals plc | 3.83B | 2.04% | 1,141,707 | 15.00M |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.76B | 4.54% | 296,364 | 7.70M |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | 4.63% | 881,683 | 1.07B |
| 174 | NAMS | NewAmsterdam Pharma Company N.V. | 3.65B | 5.52% | 209,154 | 22.50M |
| 175 | DNTH | Dianthus Therapeutics, Inc. | 3.60B | 3.02% | 364,160 | 2.04M |
| 176 | TMDX | TransMedics Group, Inc. | 3.58B | -4.13% | 548,346 | 605.49M |
| 177 | ALHC | Alignment Healthcare, Inc. | 3.58B | 0.46% | 457,998 | 3.95B |
| 178 | SYRE | Spyre Therapeutics, Inc. | 3.55B | 7.13% | 197,820 | - |
| 179 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.54B | 3.02% | 116,186 | 677.56M |
| 180 | OSCR | Oscar Health, Inc. | 3.54B | -1.25% | 2,534,891 | 11.70B |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.48B | 6.01% | 328,698 | - |
| 182 | NNNN | Anbio Biotechnology | 3.47B | 4.01% | 4,911 | 6.92M |
| 183 | DNLI | Denali Therapeutics Inc. | 3.47B | 4.24% | 2,286,776 | - |
| 184 | GPCR | Structure Therapeutics Inc. | 3.43B | 2.81% | 178,867 | - |
| 185 | LIVN | LivaNova PLC | 3.40B | -0.51% | 101,959 | 1.39B |
| 186 | BLLN | BillionToOne, Inc. | 3.33B | -2.07% | 49,500 | 305.11M |
| 187 | BKD | Brookdale Senior Living Inc. | 3.33B | 0.29% | 655,418 | 3.05B |
| 188 | LEGN | Legend Biotech Corporation | 3.26B | 3.22% | 359,790 | 1.03B |
| 189 | LQDA | Liquidia Corporation | 3.24B | 4.60% | 328,369 | 158.32M |
| 190 | ICUI | ICU Medical, Inc. | 3.18B | -0.56% | 87,716 | 2.23B |
| 191 | ALMS | Alumis Inc. | 3.16B | 7.85% | 507,178 | 24.05M |
| 192 | TNGX | Tango Therapeutics, Inc. | 3.09B | 11.32% | 1,409,264 | 62.38M |
| 193 | HNGE | Hinge Health, Inc. | 3.07B | -4.57% | 132,776 | 587.86M |
| 194 | DYN | Dyne Therapeutics, Inc. | 3.07B | 4.31% | 952,561 | - |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.03B | 1.94% | 61,893 | 803.79M |
| 196 | TWST | Twist Bioscience Corporation | 3.01B | 3.33% | 826,164 | 391.56M |
| 197 | ITGR | Integer Holdings Corporation | 2.95B | -0.41% | 104,912 | 1.85B |
| 198 | VERA | Vera Therapeutics, Inc. | 2.93B | 3.27% | 694,713 | - |
| 199 | SUPN | Supernus Pharmaceuticals, Inc. | 2.91B | 2.59% | 104,887 | 718.95M |
| 200 | PBH | Prestige Consumer Healthcare Inc. | 2.91B | -0.79% | 65,191 | 1.10B |
| 201 | VRDN | Viridian Therapeutics, Inc. | 2.90B | 4.19% | 274,492 | 70.85M |
| 202 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.88B | 2.38% | 339,609 | 588.99M |
| 203 | WRBY | Warby Parker Inc. | 2.84B | 0.43% | 472,789 | 871.91M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 2.84B | 4.72% | 251,196 | 376.07M |
| 205 | CON | Concentra Group Holdings Parent, Inc. | 2.81B | 0.14% | 164,677 | 2.16B |
| 206 | TARS | Tarsus Pharmaceuticals, Inc. | 2.80B | 4.16% | 92,140 | 451.36M |
| 207 | IDYA | IDEAYA Biosciences, Inc. | 2.75B | 2.46% | 271,345 | 218.71M |
| 208 | RCUS | Arcus Biosciences, Inc. | 2.69B | 6.07% | 361,528 | 247.00M |
| 209 | VCYT | Veracyte, Inc. | 2.62B | 0.06% | 150,499 | 517.15M |
| 210 | HAE | Haemonetics Corporation | 2.60B | -1.41% | 97,759 | 1.32B |
| 211 | TXG | 10x Genomics, Inc. | 2.55B | 0.91% | 624,279 | 642.82M |
| 212 | LFST | LifeStance Health Group, Inc. | 2.55B | 1.24% | 638,028 | 1.42B |
| 213 | NHC | National HealthCare Corporation | 2.52B | 0.10% | 32,843 | 1.52B |
| 214 | PRVA | Privia Health Group, Inc. | 2.52B | -2.59% | 148,738 | 2.12B |
| 215 | LMAT | LeMaitre Vascular, Inc. | 2.50B | -0.04% | 68,276 | 249.60M |
| 216 | BEAM | Beam Therapeutics Inc. | 2.47B | 1.29% | 2,583,669 | 139.74M |
| 217 | TVTX | Travere Therapeutics, Inc. | 2.45B | -0.78% | 255,253 | 490.73M |
| 218 | HCM | HUTCHMED (China) Limited | 2.43B | 0.21% | 5,037 | 548.51M |
| 219 | IMNM | Immunome, Inc. | 2.40B | 4.95% | 546,073 | 6.94M |
| 220 | MANE | Veradermics, Incorporated | 2.40B | 1.20% | 153,790 | - |
| 221 | HTFL | HeartFlow, Inc. | 2.40B | -0.14% | 286,537 | 176.03M |
| 222 | SRPT | Sarepta Therapeutics, Inc. | 2.39B | 29.02% | 9,487,965 | 2.20B |
| 223 | IRON | Disc Medicine, Inc. | 2.38B | 4.78% | 114,219 | - |
| 224 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.35B | -2.90% | 3,683,718 | 874.84M |
| 225 | WVE | Wave Life Sciences Ltd. | 2.32B | 5.85% | 1,211,967 | 42.73M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.31B | -3.01% | 115,697 | 1.45B |
| 227 | XRAY | DENTSPLY SIRONA Inc. | 2.30B | 0.57% | 660,427 | 3.68B |
| 228 | ADMA | ADMA Biologics, Inc. | 2.30B | -14.65% | 14,311,655 | 510.17M |
| 229 | PAHC | Phibro Animal Health Corporation | 2.29B | 1.93% | 206,697 | 1.46B |
| 230 | APLS | Apellis Pharmaceuticals, Inc. | 2.28B | 3.31% | 536,787 | 1.00B |
| 231 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.07% | 423,966 | 158.18M |
| 232 | ORKA | Oruka Therapeutics, Inc. | 2.20B | 11.15% | 255,311 | - |
| 233 | ACHC | Acadia Healthcare Company, Inc. | 2.18B | 4.23% | 447,936 | 3.31B |
| 234 | ADPT | Adaptive Biotechnologies Corporation | 2.17B | 1.29% | 729,935 | 276.98M |
| 235 | SNDX | Syndax Pharmaceuticals, Inc. | 2.16B | 1.79% | 978,406 | 172.35M |
| 236 | GRAL | GRAIL, Inc. | 2.14B | 7.18% | 263,330 | 147.17M |
| 237 | AAPG | Ascentage Pharma Group International | 2.13B | - | 58 | 54.52M |
| 238 | CLDX | Celldex Therapeutics, Inc. | 2.12B | 2.20% | 120,439 | 1.55M |
| 239 | NKTR | Nektar Therapeutics | 2.12B | 1.23% | 489,611 | 55.23M |
| 240 | ELVN | Enliven Therapeutics, Inc. | 2.11B | 13.19% | 3,551,396 | - |
| 241 | TYRA | Tyra Biosciences, Inc. | 2.04B | 4.38% | 326,759 | - |
| 242 | GLPG | Galapagos NV | 2.03B | 3.46% | 254,073 | 1.31B |
| 243 | SEM | Select Medical Holdings Corporation | 2.02B | 0.12% | 671,367 | 5.45B |
| 244 | MESO | Mesoblast Limited | 2.02B | 9.43% | 114,012 | 65.38M |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.02B | 5.97% | 519,382 | 184.42M |
| 246 | ZLAB | Zai Lab Limited | 2.01B | 4.12% | 283,249 | 460.16M |
| 247 | NEOG | Neogen Corporation | 2.01B | 1.26% | 368,182 | 880.32M |
| 248 | MLYS | Mineralys Therapeutics, Inc. | 2.01B | 6.42% | 385,283 | - |
| 249 | WGS | GeneDx Holdings Corp. | 1.99B | -0.98% | 96,563 | 427.54M |
| 250 | AUPH | Aurinia Pharmaceuticals Inc. | 1.94B | 2.53% | 298,949 | 283.06M |
| 251 | BHC | Bausch Health Companies Inc. | 1.89B | 2.00% | 481,514 | 10.27B |
| 252 | DFTX | Definium Therapeutics, Inc. | 1.89B | 6.30% | 1,537,722 | - |
| 253 | ANAB | AnaptysBio, Inc. | 1.88B | 3.92% | 88,728 | 234.60M |
| 254 | RARE | Ultragenyx Pharmaceutical Inc. | 1.86B | 4.27% | 436,954 | 673.00M |
| 255 | ADUS | Addus HomeCare Corporation | 1.84B | -0.35% | 93,963 | 1.42B |
| 256 | ZYME | Zymeworks Inc. | 1.82B | 4.41% | 170,685 | 105.97M |
| 257 | OCUL | Ocular Therapeutix, Inc. | 1.82B | 3.02% | 1,136,804 | 51.95M |
| 258 | ATEC | Alphatec Holdings, Inc. | 1.75B | -1.70% | 411,879 | 764.16M |
| 259 | MD | Pediatrix Medical Group, Inc. | 1.75B | 1.45% | 162,463 | 1.91B |
| 260 | AGIO | Agios Pharmaceuticals, Inc. | 1.74B | 4.94% | 246,152 | 54.03M |
| 261 | RLAY | Relay Therapeutics, Inc. | 1.74B | 3.28% | 438,345 | 15.36M |
| 262 | ESTA | Establishment Labs Holdings Inc. | 1.73B | 1.27% | 180,692 | 211.08M |
| 263 | CAPR | Capricor Therapeutics, Inc. | 1.72B | 3.50% | 281,792 | 11.13M |
| 264 | AORT | Artivion, Inc. | 1.71B | 0.08% | 59,133 | 441.33M |
| 265 | SION | Sionna Therapeutics, Inc. | 1.70B | 8.80% | 79,593 | - |
| 266 | SLNO | Soleno Therapeutics, Inc. | 1.69B | 4.18% | 467,612 | 190.41M |
| 267 | INVA | Innoviva, Inc. | 1.67B | 2.83% | 128,687 | 411.33M |
| 268 | MAZE | Maze Therapeutics, Inc. | 1.66B | -31.71% | 5,044,644 | 2.50M |
| 269 | ANIP | ANI Pharmaceuticals, Inc. | 1.66B | 1.21% | 44,256 | 883.37M |
| 270 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | -0.63% | 4,929,939 | 74.68M |
| 271 | TNDM | Tandem Diabetes Care, Inc. | 1.64B | -1.84% | 275,851 | 1.01B |
| 272 | NRIX | Nurix Therapeutics, Inc. | 1.64B | 10.18% | 527,230 | 83.98M |
| 273 | GRFS | Grifols, S.A. | 1.63B | 1.64% | 742,471 | 8.83B |
| 274 | VCEL | Vericel Corporation | 1.62B | -3.48% | 406,933 | 276.26M |
| 275 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 5.54% | 1,457,854 | 67.67M |
| 276 | HRMY | Harmony Biosciences Holdings, Inc. | 1.59B | 1.59% | 178,748 | 868.45M |
| 277 | IOVA | Iovance Biotherapeutics, Inc. | 1.59B | 6.49% | 5,294,898 | 263.50M |
| 278 | OGN | Organon & Co. | 1.58B | -0.49% | 589,662 | 6.22B |
| 279 | GENB | Generate Biomedicines, Inc. | 1.58B | 2.74% | 83,756 | 31.89M |
| 280 | OMCL | Omnicell, Inc. | 1.57B | 0.35% | 70,367 | 1.18B |
| 281 | IMCR | Immunocore Holdings plc | 1.57B | 3.29% | 181,820 | 400.02M |
| 282 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.56B | 3.29% | 326,727 | -665.00K |
| 283 | AHCO | AdaptHealth Corp. | 1.56B | -0.26% | 388,715 | 3.24B |
| 284 | NUVB | Nuvation Bio Inc. | 1.53B | 3.15% | 916,649 | 62.90M |
| 285 | NVAX | Novavax, Inc. | 1.53B | 1.67% | 1,055,510 | 1.12B |
| 286 | SGRY | Surgery Partners, Inc. | 1.53B | -1.75% | 196,765 | 3.31B |
| 287 | NBTX | Nanobiotix S.A. | 1.52B | 7.21% | 54,922 | 11.93M |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.50B | 4.10% | 42,530 | - |
| 289 | OCS | Oculis Holding AG | 1.50B | 3.30% | 119,996 | 1.51M |
| 290 | PLSE | Pulse Biosciences, Inc. | 1.49B | 2.87% | 59,704 | 350.00K |
| 291 | SNDA | Sonida Senior Living, Inc. | 1.49B | -0.38% | 166,850 | 336.39M |
| 292 | TRVI | Trevi Therapeutics, Inc. | 1.48B | 8.46% | 453,964 | - |
| 293 | INSP | Inspire Medical Systems, Inc. | 1.47B | -1.33% | 205,181 | 911.98M |
| 294 | UFPT | UFP Technologies, Inc. | 1.47B | 0.26% | 110,431 | 602.80M |
| 295 | ATRC | AtriCure, Inc. | 1.47B | -0.62% | 90,277 | 534.53M |
| 296 | AVAH | Aveanna Healthcare Holdings Inc. | 1.44B | 0.30% | 228,541 | 2.43B |
| 297 | PHVS | Pharvaris N.V. | 1.43B | 3.28% | 27,272 | - |
| 298 | RAPP | Rapport Therapeutics, Inc. | 1.43B | 6.05% | 69,711 | - |
| 299 | PGNY | Progyny, Inc. | 1.42B | -3.66% | 303,028 | 1.29B |
| 300 | PVLA | Palvella Therapeutics, Inc. | 1.41B | 2.81% | 96,712 | - |
| 301 | PRCT | PROCEPT BioRobotics Corporation | 1.40B | -0.96% | 268,861 | 308.05M |
| 302 | MBX | MBX Biosciences, Inc. | 1.39B | 5.03% | 100,263 | - |
| 303 | ARDX | Ardelyx, Inc. | 1.39B | 5.79% | 1,208,826 | 407.32M |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.37B | 0.77% | 123,726 | 1.84B |
| 305 | HROW | Harrow, Inc. | 1.35B | 2.84% | 144,055 | 272.30M |
| 306 | IMTX | Immatics N.V. | 1.33B | 7.50% | 152,931 | 56.67M |
| 307 | ATAI | AtaiBeckley Inc. | 1.32B | 7.25% | 1,519,912 | 4.09M |
| 308 | PRGO | Perrigo Company plc | 1.31B | -1.09% | 505,677 | 4.25B |
| 309 | NVCR | NovoCure Limited | 1.31B | 1.41% | 230,556 | 655.35M |
| 310 | IRMD | IRADIMED CORPORATION | 1.30B | 0.91% | 23,697 | 83.81M |
| 311 | VIR | Vir Biotechnology, Inc. | 1.29B | 8.17% | 1,055,790 | 68.56M |
| 312 | BHVN | Biohaven Ltd. | 1.29B | 2.38% | 582,666 | - |
| 313 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | 8.72% | 996,767 | 9.77M |
| 314 | ZBIO | Zenas BioPharma, Inc. | 1.28B | 6.17% | 134,467 | 10.00M |
| 315 | MLTX | MoonLake Immunotherapeutics | 1.28B | 6.58% | 260,217 | - |
| 316 | GLUE | Monte Rosa Therapeutics, Inc. | 1.27B | 8.02% | 486,852 | 123.67M |
| 317 | ENOV | Enovis Corporation | 1.27B | 0.20% | 122,291 | 2.25B |
| 318 | OLMA | Olema Pharmaceuticals, Inc. | 1.25B | 2.73% | 346,983 | - |
| 319 | ARDT | Ardent Health, Inc. | 1.24B | 0.70% | 36,873 | 6.32B |
| 320 | KOD | Kodiak Sciences Inc. | 1.22B | 5.26% | 198,681 | - |
| 321 | KMTS | Kestra Medical Technologies, Ltd. | 1.21B | 0.48% | 118,588 | 83.72M |
| 322 | ASTH | Astrana Health, Inc. | 1.19B | 0.12% | 75,384 | 3.18B |
| 323 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | 7.60% | 526,255 | - |
| 324 | ORIC | ORIC Pharmaceuticals, Inc. | 1.18B | 5.77% | 446,426 | - |
| 325 | USPH | U.S. Physical Therapy, Inc. | 1.14B | 1.11% | 31,624 | 773.34M |
| 326 | CNMD | CONMED Corporation | 1.13B | -0.14% | 56,453 | 1.37B |
| 327 | PHAR | Pharming Group N.V. | 1.12B | 2.57% | 7,490 | 376.13M |
| 328 | SEPN | Septerna, Inc. | 1.11B | 5.03% | 35,661 | 45.95M |
| 329 | EYPT | EyePoint, Inc. | 1.10B | 4.85% | 231,042 | 31.37M |
| 330 | PGEN | Precigen, Inc. | 1.10B | -0.96% | 1,447,765 | 6.31M |
| 331 | SVRA | Savara Inc. | 1.09B | 5.46% | 407,051 | - |
| 332 | BFLY | Butterfly Network, Inc. | 1.08B | - | 2,316,173 | 97.61M |
| 333 | INNV | InnovAge Holding Corp. | 1.07B | 0.25% | 70,712 | 915.37M |
| 334 | QDEL | QuidelOrtho Corporation | 1.07B | -3.15% | 629,096 | 2.73B |
| 335 | PNTG | The Pennant Group, Inc. | 1.06B | -0.98% | 80,222 | 947.71M |
| 336 | COLL | Collegium Pharmaceutical, Inc. | 1.06B | 0.81% | 64,538 | 780.57M |
| 337 | TVGN | Tevogen Bio Holdings Inc. | 1.05B | -0.19% | 10,137 | - |
| 338 | BCAX | Bicara Therapeutics Inc. | 1.04B | 4.90% | 144,497 | - |
| 339 | ABCL | AbCellera Biologics Inc. | 1.04B | 3.93% | 751,615 | 75.13M |
| 340 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | 0.55% | 184,083 | 1.00B |
| 341 | NEO | NeoGenomics, Inc. | 1.02B | - | 243,267 | 727.33M |
| 342 | AVBP | ArriVent BioPharma, Inc. | 1.01B | 3.87% | 68,820 | - |
| 343 | PCRX | Pacira BioSciences, Inc. | 1.00B | 0.39% | 138,297 | 726.41M |
| 344 | GERN | Geron Corporation | 999.25M | 3.31% | 3,829,634 | 183.88M |
| 345 | CMPX | Compass Therapeutics, Inc. | 995.89M | 3.75% | 374,452 | 850.00K |
| 346 | ALVO | Alvotech | 995.40M | 1.60% | 152,059 | 588.90M |
| 347 | AZTA | Azenta, Inc. | 993.55M | 1.22% | 299,863 | 595.03M |
| 348 | QURE | uniQure N.V. | 988.59M | 4.15% | 400,801 | 16.10M |
| 349 | CERT | Certara, Inc. | 986.67M | -0.80% | 637,068 | 418.84M |
| 350 | AKTS | Aktis Oncology, Inc. | 982.17M | 0.38% | 87,080 | 5.56M |
| 351 | INBX | Inhibrx Biosciences, Inc. | 980.57M | 6.35% | 51,286 | 1.30M |
| 352 | TDOC | Teladoc Health, Inc. | 974.04M | 0.74% | 1,439,785 | 2.53B |
| 353 | CRON | Cronos Group Inc. | 972.02M | 1.94% | 436,255 | 146.59M |
| 354 | SLS | SELLAS Life Sciences Group, Inc. | 967.05M | 7.81% | 2,864,438 | - |
| 355 | CDNA | CareDx, Inc. | 955.70M | 4.60% | 196,947 | 379.81M |
| 356 | SSII | SS Innovations International, Inc. | 953.32M | 1.55% | 7,589 | 42.48M |
| 357 | BLFS | BioLife Solutions, Inc. | 949.96M | 0.15% | 69,911 | 96.21M |
| 358 | STAA | STAAR Surgical Company | 946.19M | 0.74% | 230,801 | 239.44M |
| 359 | XERS | Xeris Biopharma Holdings, Inc. | 934.58M | 2.46% | 712,375 | 291.85M |
| 360 | XNCR | Xencor, Inc. | 924.07M | 5.97% | 205,463 | 125.58M |
| 361 | ABUS | Arbutus Biopharma Corporation | 895.29M | 6.26% | 887,995 | 14.08M |
| 362 | AMPH | Amphastar Pharmaceuticals, Inc. | 890.62M | 2.08% | 69,692 | 719.89M |
| 363 | OPK | OPKO Health, Inc. | 890.53M | 2.65% | 773,987 | 606.88M |
| 364 | EVO | Evotec SE | 887.77M | 6.84% | 105,193 | 887.40M |
| 365 | FTRE | Fortrea Holdings Inc. | 884.51M | -1.25% | 193,151 | 2.72B |
| 366 | CLOV | Clover Health Investments, Corp. | 883.85M | - | 1,417,779 | 1.92B |
| 367 | URGN | UroGen Pharma Ltd. | 883.10M | 2.72% | 98,693 | 109.79M |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 872.18M | 5.65% | 435,867 | - |
| 369 | GHRS | GH Research PLC | 870.58M | 4.82% | 27,864 | - |
| 370 | INMD | InMode Ltd. | 869.92M | 0.22% | 260,002 | 370.50M |
| 371 | TALK | Talkspace, Inc. | 857.10M | - | 5,409,805 | 228.87M |
| 372 | SDGR | Schrödinger, Inc. | 853.42M | -0.09% | 254,231 | 255.87M |
| 373 | JANX | Janux Therapeutics, Inc. | 851.64M | 3.24% | 672,629 | 10.00M |
| 374 | IVA | Inventiva S.A. | 848.82M | 1.33% | 74,341 | 19.93M |
| 375 | KALV | KalVista Pharmaceuticals, Inc. | 846.14M | 1.70% | 593,318 | 1.43M |
| 376 | SGP | SpyGlass Pharma, Inc. | 838.93M | 6.07% | 25,779 | - |
| 377 | PSNL | Personalis, Inc. | 837.05M | 2.83% | 410,929 | 69.65M |
| 378 | SANA | Sana Biotechnology, Inc. | 835.29M | 7.19% | 1,622,230 | - |
| 379 | EVMN | Evommune, Inc. | 830.22M | 9.66% | 136,078 | 13.00M |
| 380 | ANL | Adlai Nortye Ltd. | 829.51M | 7.20% | 53,507 | -1.35M |
| 381 | PHAT | Phathom Pharmaceuticals, Inc. | 817.14M | 3.08% | 194,154 | 175.11M |
| 382 | TLRY | Tilray Brands, Inc. | 801.57M | 3.30% | 1,339,354 | 837.32M |
| 383 | SPRY | ARS Pharmaceuticals, Inc. | 789.41M | 5.44% | 485,766 | 84.28M |
| 384 | TBPH | Theravance Biopharma, Inc. | 783.21M | 2.08% | 122,983 | 107.46M |
| 385 | MPLT | MapLight Therapeutics, Inc. | 780.31M | 5.30% | 22,467 | - |
| 386 | CSTL | Castle Biosciences, Inc. | 763.20M | 1.26% | 45,098 | 344.23M |
| 387 | CTMX | CytomX Therapeutics, Inc. | 755.63M | 4.72% | 1,181,569 | 76.20M |
| 388 | OMDA | Omada Health, Inc. | 755.42M | -4.33% | 229,870 | 260.21M |
| 389 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 750.31M | 7.51% | 33,347 | - |
| 390 | KURA | Kura Oncology, Inc. | 742.85M | 4.21% | 312,016 | 67.48M |
| 391 | OMER | Omeros Corporation | 742.33M | 2.85% | 237,948 | - |
| 392 | MNKD | MannKind Corporation | 739.44M | 4.80% | 1,378,487 | 348.97M |
| 393 | BIOA | BioAge Labs, Inc. | 726.50M | 1.61% | 232,547 | 9.00M |
| 394 | IART | Integra LifeSciences Holdings Corporation | 726.37M | -2.31% | 112,664 | 1.64B |
| 395 | LXRX | Lexicon Pharmaceuticals, Inc. | 713.90M | -2.03% | 1,546,068 | 49.80M |
| 396 | CBLL | CeriBell, Inc. | 712.92M | 0.11% | 40,016 | 89.06M |
| 397 | SLDB | Solid Biosciences Inc. | 710.39M | 8.08% | 258,174 | - |
| 398 | GYRE | Gyre Therapeutics, Inc. | 708.80M | 5.33% | 48,025 | 116.59M |
| 399 | ESPR | Esperion Therapeutics, Inc. | 708.80M | 5.34% | 1,738,579 | 403.14M |
| 400 | NUTX | Nutex Health Inc. | 706.45M | 1.90% | 41,038 | 875.26M |
| 401 | DRUG | Bright Minds Biosciences Inc. | 703.37M | 5.60% | 55,900 | - |
| 402 | GDRX | GoodRx Holdings, Inc. | 702.28M | 0.49% | 480,075 | 796.85M |
| 403 | AMN | AMN Healthcare Services, Inc. | 697.21M | -1.84% | 201,743 | 2.73B |
| 404 | RLMD | Relmada Therapeutics, Inc. | 694.37M | 8.52% | 908,887 | - |
| 405 | ARVN | Arvinas, Inc. | 693.34M | 5.34% | 170,824 | 262.60M |
| 406 | EHAB | Enhabit, Inc. | 693.13M | 0.04% | 261,722 | 1.06B |
| 407 | OCGN | Ocugen, Inc. | 685.31M | 8.85% | 5,610,334 | 4.41M |
| 408 | JBIO | Jade Biosciences, Inc. | 684.02M | 4.60% | 155,655 | - |
| 409 | ANRO | Alto Neuroscience, Inc. | 673.41M | 4.41% | 61,914 | - |
| 410 | PRME | Prime Medicine, Inc. | 671.65M | 5.68% | 813,019 | 4.63M |
| 411 | PHR | Phreesia, Inc. | 663.16M | -2.48% | 289,461 | 463.21M |
| 412 | DSGN | Design Therapeutics, Inc. | 662.98M | 4.27% | 148,294 | - |
| 413 | ETON | Eton Pharmaceuticals, Inc. | 657.83M | 4.96% | 265,979 | 79.95M |
| 414 | AVNS | Avanos Medical, Inc. | 642.91M | 1.28% | 66,845 | 701.20M |
| 415 | ANNX | Annexon, Inc. | 642.43M | 7.40% | 914,846 | - |
| 416 | EIKN | Eikon Therapeutics, Inc. | 626.22M | 4.88% | 335,494 | - |
| 417 | HSTM | HealthStream, Inc. | 625.70M | 0.57% | 105,353 | 304.06M |
| 418 | MGTX | MeiraGTx Holdings plc | 621.39M | 4.18% | 128,790 | 27.42M |
| 419 | LBRX | LB Pharmaceuticals Inc | 617.93M | 4.51% | 52,716 | - |
| 420 | TCMD | Tactile Systems Technology, Inc. | 616.62M | 2.31% | 84,307 | 329.52M |
| 421 | BVS | Bioventus Inc. | 614.73M | -0.27% | 116,872 | 568.09M |
| 422 | DRTS | Alpha Tau Medical Ltd. | 614.31M | -0.43% | 65,919 | - |
| 423 | MDXG | MiMedx Group, Inc. | 613.58M | - | 138,877 | 418.63M |
| 424 | AGMB | AgomAb Therapeutics NV | 609.21M | 7.34% | 62,959 | - |
| 425 | TECX | Tectonic Therapeutic, Inc. | 594.47M | 5.29% | 82,902 | - |
| 426 | CTKB | Cytek Biosciences, Inc. | 591.97M | -0.54% | 157,615 | 201.49M |
| 427 | REPL | Replimune Group, Inc. | 591.22M | 2.73% | 671,569 | - |
| 428 | AXGN | Axogen, Inc. | 574.46M | 1.59% | 248,603 | 225.21M |
| 429 | SIBN | SI-BONE, Inc. | 569.73M | -2.05% | 107,950 | 200.93M |
| 430 | ALLO | Allogene Therapeutics, Inc. | 564.35M | 4.75% | 1,596,470 | 22.00K |
| 431 | VALN | Valneva SE | 559.26M | 0.47% | 314,976 | 205.07M |
| 432 | YDES | YD Bio Limited | 555.88M | 2.26% | 13,833 | 510.36K |
| 433 | DBVT | DBV Technologies S.A. | 550.46M | 2.86% | 159,098 | 5.50M |
| 434 | AVR | Anteris Technologies Global Corp. | 547.42M | 4.45% | 177,644 | 1.91M |
| 435 | ZVRA | Zevra Therapeutics, Inc. | 545.43M | 1.53% | 225,158 | 106.47M |
| 436 | CMPS | COMPASS Pathways plc | 541.92M | 8.05% | 804,601 | - |
| 437 | YI | 111, Inc. | 535.92M | -2.44% | 21,014 | 1.91B |
| 438 | ZURA | Zura Bio Limited | 530.38M | 3.90% | 159,355 | - |
| 439 | EMBC | Embecta Corp. | 528.83M | -0.89% | 189,741 | 1.08B |
| 440 | CRMD | CorMedix Inc. | 526.48M | 3.10% | 344,203 | 311.71M |
| 441 | IRWD | Ironwood Pharmaceuticals, Inc. | 525.05M | 5.92% | 372,725 | 296.15M |
| 442 | BNR | Burning Rock Biotech Limited | 524.70M | 0.50% | 133,133 | 77.14M |
| 443 | FLGT | Fulgent Genetics, Inc. | 519.68M | 1.84% | 247,266 | 322.67M |
| 444 | CATX | Perspective Therapeutics, Inc. | 518.40M | 6.06% | 271,556 | 884.00K |
| 445 | BBNX | Beta Bionics, Inc. | 516.39M | 3.51% | 194,596 | 100.25M |
| 446 | NAUT | Nautilus Biotechnology, Inc. | 515.32M | 3.29% | 621,789 | - |
| 447 | UPB | Upstream Bio, Inc. | 509.58M | 11.60% | 242,611 | 2.80M |
| 448 | ADCT | ADC Therapeutics SA | 509.45M | 1.78% | 148,521 | 81.36M |
| 449 | CTNM | Contineum Therapeutics, Inc. | 507.21M | 10.18% | 40,045 | - |
| 450 | FDMT | 4D Molecular Therapeutics, Inc. | 505.41M | 7.84% | 312,800 | 85.21M |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 6.22M |
| 452 | AQST | Aquestive Therapeutics, Inc. | 502.83M | 6.19% | 676,163 | 44.55M |
| 453 | RCKT | Rocket Pharmaceuticals, Inc. | 501.59M | 8.20% | 1,650,648 | - |
| 454 | LYEL | Lyell Immunopharma, Inc. | 492.48M | 7.26% | 16,814 | 36.00K |
| 455 | LRMR | Larimar Therapeutics, Inc. | 491.37M | 3.50% | 3,294,500 | - |
| 456 | PRTA | Prothena Corporation plc | 489.88M | 4.24% | 164,001 | 9.68M |
| 457 | RIGL | Rigel Pharmaceuticals, Inc. | 487.51M | 1.00% | 69,580 | 294.28M |
| 458 | OFIX | Orthofix Medical Inc. | 473.70M | 0.68% | 46,147 | 822.31M |
| 459 | ENGN | enGene Holdings Inc. | 473.62M | 2.46% | 40,161 | - |
| 460 | KMDA | Kamada Ltd. | 473.03M | - | 10,806 | 180.46M |
| 461 | FULC | Fulcrum Therapeutics, Inc. | 470.86M | 5.52% | 142,099 | 80.00M |
| 462 | TRDA | Entrada Therapeutics, Inc. | 463.24M | 5.49% | 35,033 | 25.42M |
| 463 | ASMB | Assembly Biosciences, Inc. | 462.87M | 3.37% | 19,215 | 72.30M |
| 464 | ANGO | AngioDynamics, Inc. | 457.51M | 4.42% | 191,715 | 307.31M |
| 465 | MRVI | Maravai LifeSciences Holdings, Inc. | 456.72M | 1.30% | 628,749 | 185.74M |
| 466 | STTK | Shattuck Labs, Inc. | 450.50M | 2.86% | 246,411 | 1.00M |
| 467 | ABSI | Absci Corporation | 449.88M | -2.33% | 4,616,460 | 2.80M |
| 468 | NPCE | NeuroPace, Inc. | 448.44M | 0.38% | 96,941 | 99.99M |
| 469 | VSTM | Verastem, Inc. | 447.08M | 3.25% | 1,196,167 | 30.91M |
| 470 | VREX | Varex Imaging Corporation | 446.24M | 0.28% | 58,629 | 854.40M |
| 471 | DNA | Ginkgo Bioworks Holdings, Inc. | 443.70M | 5.02% | 368,534 | 170.16M |
| 472 | IVVD | Invivyd, Inc. | 439.43M | 8.74% | 885,523 | 53.43M |
| 473 | ALT | Altimmune, Inc. | 438.35M | 4.02% | 706,152 | 41.00K |
| 474 | EBS | Emergent BioSolutions Inc. | 433.47M | 3.87% | 383,613 | 742.90M |
| 475 | AVIR | Atea Pharmaceuticals, Inc. | 431.82M | 1.69% | 128,705 | - |
| 476 | ACRS | Aclaris Therapeutics, Inc. | 429.92M | 8.03% | 708,973 | 7.83M |
| 477 | MYGN | Myriad Genetics, Inc. | 428.27M | -0.65% | 373,628 | 824.50M |
| 478 | AUNA | Auna S.A. | 426.81M | -0.86% | 78,102 | 1.30B |
| 479 | RGNX | REGENXBIO Inc. | 425.29M | 5.51% | 276,848 | 170.44M |
| 480 | EPRX | Eupraxia Pharmaceuticals Inc. | 423.55M | 6.97% | 86,915 | - |
| 481 | NMRA | Neumora Therapeutics, Inc. | 422.74M | 2.43% | 330,757 | - |
| 482 | LXEO | Lexeo Therapeutics, Inc. | 422.60M | 5.27% | 274,291 | - |
| 483 | AURA | Aura Biosciences, Inc. | 419.76M | 4.75% | 80,899 | - |
| 484 | VNDA | Vanda Pharmaceuticals Inc. | 418.48M | 3.81% | 397,803 | 216.11M |
| 485 | PACB | Pacific Biosciences of California, Inc. | 417.52M | - | 1,166,402 | 160.01M |
| 486 | CYH | Community Health Systems, Inc. | 411.72M | 1.71% | 284,606 | 12.49B |
| 487 | STRO | Sutro Biopharma, Inc. | 411.36M | 5.35% | 292,647 | 102.48M |
| 488 | KIDS | OrthoPediatrics Corp. | 408.51M | 1.57% | 69,310 | 236.35M |
| 489 | CV | CapsoVision, Inc. | 404.73M | -0.58% | 181,241 | 13.09M |
| 490 | IPSC | Century Therapeutics, Inc. | 402.58M | - | 353,313 | 109.16M |
| 491 | LCTX | Lineage Cell Therapeutics, Inc. | 396.05M | 7.43% | 974,408 | 14.56M |
| 492 | SRTA | Strata Critical Medical, Inc. | 384.49M | 2.67% | 261,534 | 197.14M |
| 493 | NRC | National Research Corporation | 384.41M | -3.10% | 21,695 | 137.39M |
| 494 | PRTC | PureTech Health plc | 382.24M | 1.11% | 264 | 6.39M |
| 495 | MNPR | Monopar Therapeutics Inc. | 377.03M | 2.12% | 102,759 | - |
| 496 | BNTC | Benitec Biopharma Inc. | 376.01M | 2.29% | 25,168 | - |
| 497 | LAB | Standard BioTools Inc. | 374.47M | 1.06% | 443,951 | 85.33M |
| 498 | CADL | Candel Therapeutics, Inc. | 372.09M | 5.61% | 665,553 | - |
| 499 | AKBA | Akebia Therapeutics, Inc. | 371.01M | 1.84% | 549,232 | 236.20M |
| 500 | GLSI | Greenwich LifeSciences, Inc. | 370.05M | 4.01% | 76,923 | - |